Corpus Intelligence IC Memo — MAGNOLIA REGIONAL HEALTH SYSTEM INC 2026-04-26 04:05 UTC
IC Memo — MAGNOLIA REGIONAL HEALTH SYSTEM INC
Investment Committee Memorandum | AR | 29 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MAGNOLIA REGIONAL HEALTH SYSTEM INC

CCN 040067 | COLUMBIA, AR | 29 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MAGNOLIA REGIONAL HEALTH SYSTEM INC is a 29-bed under-performing / distressed in COLUMBIA, AR with $25.9M in net patient revenue and a -21.3% operating margin. The hospital serves a payer mix of 44.5% Medicare, 9.9% Medicaid, and 45.6% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.3% to -14.0% (+736bps).

Net Revenue HCRIS$25.9M
Current EBITDA COMPUTED$-5.5M
Operating Margin COMPUTED-21.3%
Occupancy HCRIS34.1%
Revenue / Bed COMPUTED$893K
Net-to-Gross HCRIS36.2%
Distress Probability ML54.9%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
52
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -21.3% places it below the state median. Among 52 size-comparable peers (14-58 beds), the median margin is -14.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-58), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MAGNOLIA REGIONAL HEALTH SYSTE (Target)AR29$25.9M-21.3%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
FORREST CITY MEDICAL CENTERAR48$30.3M-17.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$544K+210bp18mo
Cost to Collect4.5%2.5%$518K+200bp12mo
Denial Rate Reduction12.0%6.5%$513K+198bp12mo
A/R Days Reduction5200.0%3800.0%$315K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$544K
Cost to Collect
$518K
Denial Rate Reduction
$513K
A/R Days Reduction
$315K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-5.5M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-3.6M
Current Margin-21.3%
Pro Forma Margin-14.0%
WC Released (1x)$993K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.5M$-17.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.5M$-21.9M0.00x-100.0%
Bull Case9.0x11.0x$-7.6M$-18.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.6M$-22.3M0.00x-100.0%
Bear Case11.0x10.0x$-9.3M$-24.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.3M$-29.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 34.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 14-58 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-24.5% / P50=-14.2% / P75=-0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.